cro.directory
← Compare landing

Cyagen Biosciences vs VIRSCIO

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/cyagen/virscio

CategoryCyagen BiosciencesVIRSCIO
Listed sitecrocro
SummaryCyagen provides genetically engineered animal models, custom cell lines, and viral packaging services for preclinical drug discovery, with specialized platforms including HUGO-GT™ and HUGO-Ab™ for humanized target validation and antibody screening.Virscio runs African green monkey studies for efficacy, safety, PK/PD and delivery alongside digital histopathology and molecular biology. Its GLP-operated, AAALAC-accredited primate program supports IND-enabling work in CNS, ophthalmology, and gene therapy.
Services
  • Specialized & Large-Animal Models
  • In Vivo Efficacy Models
  • Preclinical In Vivo Studies
  • In Vitro Pharmacology
  • Preclinical In Vitro Studies
  • Translational Research
  • Immunology & Inflammation Services
  • Virology Services
  • Preclinical In Vivo Studies
  • In Vivo Efficacy Models
  • In Vivo PK / PD Studies
  • Specialized & Large-Animal Models
  • Pathology & Histology Services
  • Translational Research
  • Regulatory Affairs
Modalities
  • Biologics (Monoclonal Antibodies)
  • Cell Therapy
  • Gene Therapy
  • AAV / Viral Vector Platform
  • Gene Therapy
  • Cell Therapy
Indications
  • Oncology
  • Immunology
  • Neurology
  • Metabolic
  • Cardiovascular
  • Infectious Disease
  • Ophthalmology
  • Neurology
  • Ophthalmology
  • Cardiovascular
  • Metabolic
Locations
  • Headquarters, Santa Clara, California, United States
  • New Haven, New Haven, CT, United States
Certifications
  • AAALAC International · Identifier: AAALAC-accredited facilities
Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.